Related Experiment Videos
[Serum thyroglobulin (S-hTG): a tumor marker in patients with differentiated thyroid carcinoma (author's transl)]
Strahlentherapie
|June 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Differentiated thyroid cancer: prognostic factors and influence of treatment on the outcome in 441 patients.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2001
[The radiotherapy of heterotopic ossifications in paraplegics. The preliminary results].
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·1995
[Analgetic irradiation of degenerative-inflammatory skeletal diseases. Benefits and risks].
Deutsche medizinische Wochenschrift (1946)·1993
[The value of a new IRMA for determining thyroglobulin].
Nuklearmedizin. Nuclear medicine·1992
Late cervical lymph node recurrence in differentiated thyroid carcinoma. An inherent problem of 131I beta dose distribution in small tumor deposits?
Nuklearmedizin. Nuclear medicine·1992
Results of neutron therapy of soft-tissue sarcomas.
Strahlentherapie·1985
Results of curative pion therapy at SIN.
Strahlentherapie·1985
The RENT-project: radiobiological results and planned clinical application.
Strahlentherapie·1985
Neutron and neutron boost irradiation of soft tissue sarcomas.
Strahlentherapie·1985
Frailty Assessment and Its Impact in Hospital Outcomes After Cardiac Surgery - A Prospective Observational Study.
Brazilian journal of cardiovascular surgery·2026
Changes in Susceptibility to Cannabis Use From Late Childhood to Early Adolescence.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2026
Comparing methodological approaches for outlier detection: a cross-sectional study of older persons in 2,744 Australian long-term care facilities.
International journal for quality in health care : journal of the International Society for Quality in Health Care·2026
FIN-EGFR: real-world treatment outcomes by EGFR mutational subtypes in NSCLC in Southern Finland.
Acta oncologica (Stockholm, Sweden)·2026